This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Adenocarcinoma and ductal carcinoma of pancreas
C3_PANCREAS_ADENO_DUCTAL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1159 |
4. Check minimum number of eventsNone |
1159 |
5. Include endpointsNone |
1159 |
6. Filter based on genotype QC (FinnGen only) |
1159 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma and ductal carcinoma of pancreas
based on the number of shared cases.
Similar with more cases:
- Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of pancreas
- Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1159 | 490 | 669 |
| Unadjusted period prevalence (%) | 0.24 | 0.17 | 0.29 |
| Median age at first event (years) | 70.13 | 69.87 | 70.32 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1063
- Matched controls
- 10629
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
51.1
323.0
416
132
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
118.7
323.0
392
52
130
Kela drug reimbursment
Malignant tumour
41.9
323.0
763
608
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
323.0
581
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
90.5
323.0
426
78
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
212.3
323.0
460
38
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
484.5
323.0
688
40
JLC30
NOMESCO Finland
Pancreatoduodenectomy
295.9
289.3
283
13
A04AA02
ATC
granisetron; systemic, transdermal
22.8
273.6
419
295
A03FA01
ATC
metoclopramide; systemic, rectal
11.4
273.2
676
1411
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
25.4
254.9
372
220
N02AA05
ATC
oxycodone; systemic
9.2
213.3
557
1133
H02AB02
ATC
dexamethasone; systemic
10.8
201.2
444
660
Z51.5
ICD-10 Finland
Palliative care
13.7
199.6
377
409
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
185.6
193.0
197
13
8140/3-C25.0
ICD-O-3
Adenocarcinoma, NOS, of head of pancreas
+∞
176.0
164
*
UJK02
NOMESCO Finland
ERCP
26.8
176.0
249
120
L01BC06
ATC
capecitabine; oral
17.9
162.4
265
193
K83.1
ICD-10 Finland
Obstruction of bile duct
45.3
159.8
197
53
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
62.9
157.8
183
35
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
18.2
155.2
251
177
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
38.0
155.1
199
64
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
49.1
151.7
184
45
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
26.0
150.4
214
102
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
181.7
138.2
142
9
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
+∞
129.9
122
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.8
121.2
250
293
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
29.5
117.9
161
64
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
284.7
102.7
103
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
13.1
98.3
181
164
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
11.5
96.7
190
197
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.6
88.4
206
288
JAH01
NOMESCO Finland
Laparoscopy
12.2
87.9
167
160
D76
ICPC
Malignant neoplasm pancreas
317.1
87.1
87
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
18.9
86.7
136
82
R4190
NOMESCO Finland
Nutritional therapy
13.5
78.4
141
119
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
33.0
77.4
102
34
A04AA01
ATC
ondansetron; systemic, rectal
6.9
76.9
208
360
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
16.2
76.6
127
88
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.6
76.6
142
128
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
18.3
76.5
121
74
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.0
74.9
200
339
JN4BD
NOMESCO Finland
Extensive body CT
4.7
72.8
288
780
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
30.2
69.8
94
34
JN4CD
NOMESCO Finland
Very extensive body CT
7.7
68.5
169
253
8140/3-C25.2
ICD-O-3
Adenocarcinoma, NOS, of tail of pancreas
+∞
66.3
63
*
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
+∞
66.3
63
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
10.1
65.5
136
152
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.2
63.8
478
2172
JN4AD
NOMESCO Finland
Body CT examination
5.2
62.6
214
488
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
15.2
62.0
105
76
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
219.1
60.8
62
*
A06AH03
ATC
naloxegol; oral
22.2
59.8
88
43
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
48.1
59.4
72
16
WZC30
NOMESCO Finland
Teaching
4.0
57.4
263
799
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
200.5
55.5
57
*
JDE00
NOMESCO Finland
Gastrojejunostomy
56.6
54.4
64
12
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
53.6
255
795
C25
ICD-10 Finland
Malignant neoplasm of pancreas
147.6
53.4
56
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.9
53.0
192
460
R50.9
ICD-10 Finland
Fever, unspecified
3.8
52.6
260
837
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.5
52.3
167
347
L03AA02
ATC
filgrastim; parenteral
9.5
49.7
106
123
8140/3-C25.1
ICD-O-3
Adenocarcinoma, NOS, of body of pancreas
+∞
49.3
47
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.0
49.0
222
658
K83.0
ICD-10 Finland
Cholangitis
14.7
48.6
83
61
JLC10
NOMESCO Finland
Distal pancreatectomy
59.0
48.0
56
10
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
+∞
47.2
45
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
23.0
45.0
65
30
B01AB10
ATC
tinzaparin; parenteral
4.7
44.9
165
398
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.5
43.7
169
428
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
46.3
43.6
53
12
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
65.5
43.6
50
8
A98
ICPC
Health maint/preventive medicine
0.4
41.9
637
8440
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
27.3
41.5
57
22
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
19.0
41.0
63
35
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
12.0
40.7
76
68
JMA10
NOMESCO Finland
Transabdominal total splenectomy
28.9
40.7
55
20
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.3
40.6
114
200
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
11.6
40.2
76
70
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
42.8
39.7
49
12
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
26.3
39.7
55
22
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.3
39.4
127
264
B01AB05
ATC
enoxaparin; parenteral
2.4
35.8
434
2392
A04AA55
ATC
palonosetron, combinations; systemic
8.4
33.3
75
95
WW500
NOMESCO Finland
Blood transfusion
5.3
33.2
106
217
A10AE04
ATC
insulin glargine; parenteral
3.4
32.4
177
595
R18
ICD-10 Finland
Ascites
8.8
32.4
71
86
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
31.0
145
431
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
30.2
302
1480
JAH00
NOMESCO Finland
Laparotomy
5.9
30.2
87
157
191
Kela drug reimbursment
Erlotinib
33.7
30.2
39
12
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
29.7
212
852
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
25.9
28.9
40
16
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
148.9
27.8
29
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
26.3
214
929
1570A
ICD-9 Finland
Malignant neoplasm of pancreas, Head of pancreas
+∞
26.1
25
*
1CD01
NOMESCO Finland
NA
34.0
25.7
33
10
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
9.4
25.5
53
59
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
7.7
25.2
59
80
L01XE03
ATC
[U] erlotinib; oral
35.4
24.4
31
9
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
23.9
178
730
A06AD11
ATC
lactulose; oral
2.3
23.4
242
1185
A02BC02
ATC
pantoprazole; systemic
2.0
23.4
728
5571
N02AX02
ATC
tramadol; systemic, rectal
1.9
23.2
508
3409
J01MA12
ATC
levofloxacin; systemic
2.2
23.1
276
1447
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
22.7
23.1
33
15
ZX122
NOMESCO Finland
Intra-arterial
18.4
22.3
34
19
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
24.5
22.2
31
13
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
22.8
21.8
31
14
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.3
21.7
68
136
WX004
NOMESCO Finland
Patient-controlled sedation
17.9
21.4
33
19
L03AA13
ATC
pegfilgrastim; parenteral
4.6
21.1
75
172
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
15.2
20.8
34
23
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
20.8
371
2282
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
20.6
236
1203
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
42.6
20.5
25
6
K85.8
ICD-10 Finland
Other acute pancreatitis
17.7
20.1
31
18
N05BA06
ATC
lorazepam; systemic, sublingual
3.5
20.0
96
290
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
58.7
20.0
23
*
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
74.9
19.7
22
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
12.4
19.7
35
29
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.4
19.2
58
112
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.0
18.9
77
202
JLA00
NOMESCO Finland
Exploration of pancreas
101.8
18.6
20
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
12.6
18.2
32
26
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
17.8
354
2236
JLA10
NOMESCO Finland
Biopsy of pancreas
182.9
17.6
18
*
A04AD12
ATC
aprepitant; systemic
6.2
17.4
47
79
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
16.3
17.1
27
17
ZX120
NOMESCO Finland
Intravenous
2.5
16.7
142
622
B01AB04
ATC
dalteparin; parenteral
3.3
16.1
85
276
WX402
NOMESCO Finland
General anaesthesia
2.2
16.1
173
850
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
60.9
15.8
18
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
6.4
15.3
40
65
K86.1
ICD-10 Finland
Other chronic pancreatitis
8.6
15.0
32
38
N05AD01
ATC
haloperidol; systemic
3.8
14.7
63
174
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.4
14.7
38
61
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
14.6
139
643
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.9
14.4
91
334
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.5
14.4
101
1971
TJA10
NOMESCO Finland
Laparocentesis
19.4
14.3
21
11
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.5
14.2
123
2245
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
14.2
359
4904
N02AA01
ATC
morphine; systemic, rectal
5.9
14.2
39
68
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
30.5
13.9
18
6
C10AA05
ATC
atorvastatin; oral
0.6
13.9
225
3434
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
141.7
13.5
14
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.6
13.3
189
2998
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
40.6
13.2
16
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.9
13.1
36
63
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
13.0
219
3325
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
50.6
12.9
15
*
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
5.2
12.8
39
77
P20
ICPC
Memory disturbance
0.3
12.6
38
1035
C10AA07
ATC
rosuvastatin; oral
0.5
12.3
96
1818
TPX15
NOMESCO Finland
Removal of vascular injection port
18.3
12.1
18
10
A41.8
ICD-10 Finland
Other specified sepsis
4.6
12.0
41
92
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.1
11.9
37
75
N06DX01
ATC
memantine; oral
0.1
11.9
7
477
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
11.9
124
2153
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.4
11.9
35
67
M25.5
ICD-10 Finland
Pain in joint
0.5
11.9
87
1686
H25.1
ICD-10 Finland
Senile nuclear cataract
0.5
11.7
152
2486
JFA65
NOMESCO Finland
Endoscopic insertion of ileum stent
65.7
11.6
13
*
SPAT1053
SPAT
Memory test
0.4
11.6
65
1381
JDE01
NOMESCO Finland
Laparoscopic gastroenterostomy
+∞
11.5
11
*
ZX121
NOMESCO Finland
Central venous catheter
15.2
11.3
18
12
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
11.3
304
4171
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.5
11.2
130
2197
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
12.9
11.2
19
15
K02.1
ICD-10 Finland
Caries of dentine
0.6
11.1
257
3651
G04BD12
ATC
mirabegron; oral
0.3
11.0
23
742
M79.6
ICD-10 Finland
Pain in limb
0.6
10.9
152
2444
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
15.7
10.8
17
11
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
10.7
328
2288
WX002
NOMESCO Finland
Sedation and analgesia
1.7
10.4
233
1487
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
10.4
53
1171
JKD00
NOMESCO Finland
Anastomosis of gallbladder to jejunum
+∞
10.4
10
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.6
10.4
272
3774
A79
ICPC
Malignancy NOS
4.8
10.3
33
70
Z01.2
ICD-10 Finland
Dental examination
0.6
10.2
152
2406
WX892
NOMESCO Finland
Monitored bed care
2.2
9.9
98
462
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
9.9
39
951
WX320
NOMESCO Finland
Spinalanesthesy
0.5
9.8
89
1620
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
20.2
9.8
14
7
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.6
9.8
252
3519
R5140
NOMESCO Finland
Monitoring the use of the aid
0.3
9.6
21
661
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
9.5
8
432
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
9.5
59
216
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.6
9.4
150
2346
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
100.9
9.4
10
*
PHN72
NOMESCO Finland
Plastic repair of superior mesenteric or portal vein
+∞
9.4
9
*
6706
FHL
Pancreatic homeectomy (eg Whipple)
+∞
9.4
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
9.2
278
1921
K86.8
ICD-10 Finland
Other specified diseases of pancreas
13.8
9.2
15
11
J94.8
ICD-10 Finland
Other specified pleural conditions
4.0
9.2
35
89
I81
ICD-10 Finland
Portal vein thrombosis
11.6
9.1
16
14
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
9.1
133
2127
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
9.0
466
5702
JKA20
NOMESCO Finland
Cholecystectomy
3.2
8.9
45
144
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
18.8
8.9
13
7
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
24.2
8.9
12
5
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.8
8.9
28
59
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
8.8
91
438
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.6
8.8
141
2209
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.4
8.8
31
789
C10AX09
ATC
ezetimibe; oral
0.4
8.8
28
745
XKD00
NOMESCO Finland
Uroflowmetry
0.5
8.7
81
1470
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.6
8.7
37
104
325
Kela drug reimbursment
Erlotinib
50.4
8.7
10
*
L03
ICPC
Low back symptom/complaint
0.5
8.7
84
1506
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
8.6
131
2081
B01AC04
ATC
clopidogrel; oral
0.5
8.6
79
1437
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
8.6
139
2171
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
8.3
8.6
18
22
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
27.7
8.5
11
*
K31.5
ICD-10 Finland
Obstruction of duodenum
27.7
8.5
11
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
27.7
8.5
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.4
8.4
37
864
R83
ICPC
Respiratory infection other
0.4
8.4
37
867
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.5
8.4
91
1575
8500/3-C25.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of body of pancreas
+∞
8.3
8
*
1571A
ICD-9 Finland
Malignant neoplasm of pancreas, Body of pancreas
+∞
8.3
8
*
PHC71
NOMESCO Finland
Suture of mesenteric or portal vein
+∞
8.3
8
*
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
8.6
8.3
17
20
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
8.3
47
1002
R11
ICD-10 Finland
Nausea and vomiting
2.2
8.2
86
414
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
8.2
115
625
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.4
8.2
41
911
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.6
8.2
162
2413
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.1
8.2
21
35
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
33.6
8.1
10
*
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
33.6
8.1
10
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
17.3
8.1
12
7
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.5
8.0
82
1448
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.3
8.0
28
66
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
22.2
8.0
11
5
WX882
NOMESCO Finland
High dependency care
3.2
7.9
40
129
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.4
7.9
40
889
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
7.9
202
2854
K86.3
ICD-10 Finland
Pseudocyst of pancreas
7.8
7.9
17
22
L15
ICPC
Knee symptom/complaint
0.5
7.9
75
1352
I50.9
ICD-10 Finland
Heart failure, unspecified
0.5
7.9
69
1275
F03
ICD-10 Finland
Unspecified dementia
0.2
7.9
5
323
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.4
7.9
45
953
207
Kela drug reimbursment
Chronic arrhythmias
0.5
7.8
66
1234
H26.4
ICD-10 Finland
After-cataract
0.4
7.8
31
754
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.5
7.7
55
1084
R03AC02
ATC
salbutamol; inhalant
0.7
7.7
287
3774
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
45.3
7.7
9
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.7
7.7
50
191
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
7.6
50
1010
A21
ICPC
Risk factor for malignancy
18.5
7.6
11
6
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
25.2
7.6
10
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
7.6
271
1939
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
5.5
7.5
21
39
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.4
7.5
41
885
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.1
7.4
22
44
WX610
NOMESCO Finland
Patient controlled analgesia
8.4
7.3
15
18
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
8.4
7.3
15
18
C25.3
ICD-10 Finland
Malignant neoplasm: Pancreatic duct
+∞
7.3
7
*
8500/3-C25.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of tail of pancreas
+∞
7.3
7
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.4
7.1
59
257
L13
ICPC
Hip symptom/complaint
0.5
7.1
58
1097
H81
ICPC
Excessive ear wax
0.5
7.1
72
1273
DFF00
NOMESCO Finland
Pure tone audiometry
0.4
7.0
21
571
SDA02
NOMESCO Finland
Parodonthologic therapy
0.6
6.9
129
1959
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.2
6.9
10
389
AA1AD
NOMESCO Finland
CT of head and brain
0.6
6.9
127
1934
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.4
6.9
31
93
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.6
6.9
143
2119
D82
ICPC
Teeth/gum disease
0.6
6.8
124
1896
R05
ICPC
Cough
0.6
6.8
81
1375
L57.0
ICD-10 Finland
Actinic keratosis
0.4
6.7
33
742
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.7
6.7
219
2966
CJB10
NOMESCO Finland
Laser discission of secondary cataract
0.4
6.7
26
637
D13
ICPC
Jaundice
22.7
6.7
9
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
22.7
6.7
9
*
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
6.5
6.6
16
25
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.6
461
3750
E13
ICD-10 Finland
Other specified diabetes mellitus
12.3
6.6
11
9
M48.0
ICD-10 Finland
Spinal stenosis
0.5
6.5
48
937
JLB12
NOMESCO Finland
Transduodenal endoscopic incision of pancreatic duct orifice
70.2
6.4
7
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.6
6.4
45
179
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.8
6.4
25
67
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.5
6.4
48
198
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.7
6.4
290
3713
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.6
6.4
128
1913
ZX095
NOMESCO Finland
Combined chemoradiotherapy
6.6
6.3
15
23
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.4
6.3
27
639
J01CA04
ATC
amoxicillin; systemic
0.7
6.3
565
6497
C10AC01
ATC
colestyramine; oral
2.8
6.3
37
133
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
6.0
6.3
16
27
G47.3
ICD-10 Finland
Sleep apnoea
0.6
6.3
86
1409
E14.8
ICD-10 Finland
Unspecified diabetes mellitus, with unspecified complications
9.3
6.3
12
13
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
9.3
6.3
12
13
V03AF03
ATC
calcium folinate; systemic
9.3
6.3
12
13
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.4
6.3
25
605
D19
ICPC
Teeth/gum symptom/complaint
0.6
6.3
89
1447
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
+∞
6.3
6
*
1579X
ICD-9 Finland
Malignant neoplasm of pancreas, Pancreas, part unspecified
+∞
6.3
6
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.6
6.2
110
1693
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.4
6.2
20
528
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.4
6.2
19
512
ZXA05
NOMESCO Finland
Left side
0.6
6.2
140
2043
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
5.4
6.2
17
32
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.7
6.1
195
2661
KMAK
NOMESCO Finland
NA
0.7
6.1
259
3359
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.3
6.1
13
415
KED22
NOMESCO Finland
Transurethral resection of prostate
0.4
6.1
20
523
N07BC02
ATC
methadone; systemic
12.6
6.1
10
8
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
12.6
6.1
10
8
SPAT1262
SPAT
Handing over of treatment supplies
1.5
6.1
200
1398
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
3.6
6.0
25
71
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000570) Elastase.pancreatic [Mass/mass] in Stool
360
272
18.75
307.65
1.6
1.5
ug/g
134.5
275.4
18.39
186
161
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
311
221
18.87
307.65
8.6
3.0
u/ml
5767.6
600.8
2.69
296
205
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
665
1139
12.35
307.65
7.9
4.0
ug/l
107.9
23.4
1.13
640
952
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
428
399
16.42
307.65
8.7
3.0
u/ml
26753.4
1030.6
1.12
396
336
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
140
84
18.82
171.01
1.2
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
374
964
5.25
140.68
4.1
2.1
g/l
0.2
0.2
5.21
357
894
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
385
1068
4.90
131.52
6.3
2.7
umol/l
38.1
8.9
16.31
360
941
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
646
3004
3.60
100.67
6.4
2.5
u/l
46.6
58.0
5.99
617
2740
(40768441) Liver Pathology biopsy report
79
65
12.97
80.34
1.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
603
8907
0.33
75.47
3.6
5.4
mmol/l
2.6
2.6
0.25
509
8003
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
564
8594
0.33
74.55
3.4
4.8
mmol/l
1.4
1.4
3.71
471
7701
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
576
8677
0.33
73.91
3.4
4.8
mmol/l
4.4
4.5
0.63
483
7846
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
267
884
3.63
67.08
9.1
2.2
u/l
175.3
35.4
0.61
247
737
(3023368) Bacteria identified in Blood by Culture
568
3002
2.75
61.66
7.6
4.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
558
8310
0.37
61.03
3.2
4.3
mmol/l
1.3
1.3
1.05
468
7382
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
627
8776
0.38
56.32
4.0
5.1
mmol/l
6.9
6.1
15.37
553
7798
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
545
8073
0.39
54.57
3.4
4.7
mu/l
2.1
2.2
0.28
454
7196
(3000963) Hemoglobin [Mass/volume] in Blood
769
9645
0.40
44.52
59.8
25.1
g/l
116.5
133.3
164.31
747
9445
(3010813) Leukocytes [#/volume] in Blood
769
9644
0.40
44.46
59.4
25.0
e9/l
7.8
6.9
15.08
738
9303
(3026361) Erythrocytes [#/volume] in Blood
769
9642
0.40
44.34
59.4
24.9
e12/l
3.9
4.4
106.48
739
9302
(3035941) MCH [Entitic mass]
769
9641
0.40
44.28
59.2
24.8
pg
30.1
30.4
7.27
750
9442
(3007461) Platelets [#/volume] in Blood
769
9641
0.40
44.28
59.4
24.9
e9/l
260.0
240.1
8.36
744
9340
(3024731) MCV [Entitic volume]
769
9641
0.40
44.28
59.3
24.9
fl
91.4
91.7
1.07
750
9444
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
624
8490
0.43
43.34
7.0
6.5
mmol/mol
45.3
40.8
14.65
571
7708
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
498
2828
2.33
41.94
7.9
3.2
u/l
62.2
35.2
10.51
481
2677
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
418
6587
0.43
40.91
3.0
3.8
pmol/l
15.0
15.1
0.22
350
5842
(3024561) Albumin [Mass/volume] in Serum or Plasma
675
4427
2.26
39.33
15.1
4.7
g/l
30.5
34.7
58.13
657
4108
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
623
8353
0.45
37.87
42.9
16.1
ml/min/173m2
83.6
73.5
28.32
563
6923
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
740
5099
2.25
37.37
29.6
6.2
umol/l
20.8
12.2
7.18
723
4817
(40762365) Oxygen content in Arterial blood by calculation
32
22
14.93
35.75
5.8
1.7
ml/dl
13.3
14.5
0.85
32
17
(3012095) Magnesium [Moles/volume] in Serum or Plasma
325
1629
2.38
35.45
3.4
3.2
mmol/l
0.8
0.8
1.36
309
1513
(4035726)
208
844
2.78
35.26
1.2
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
301
1481
2.39
34.07
2.2
2.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
765
9417
0.45
34.06
45.4
20.5
mmol/l
3.9
4.0
6.65
743
9137
(3032080) INR in Blood by Coagulation assay
654
4390
2.12
33.95
11.1
11.0
inr
1.2
1.3
2.25
174
1184
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
761
9372
0.45
33.41
33.1
11.2
u/l
43.3
25.1
31.78
740
8963
(3019550) Sodium [Moles/volume] in Serum or Plasma
765
9397
0.45
33.12
45.7
20.3
mmol/l
137.5
139.6
57.11
743
9125
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
354
2023
2.08
26.79
11.4
3.1
mmol/l
2.5
2.5
7.24
344
1773
(40761511) CBC panel - Blood by Automated count
745
9079
0.50
26.53
36.5
16.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
56
114
5.11
26.25
1.3
1.6
g/l
0.9
0.9
0.06
35
89
(3033658) Prothrombin time (PT) actual/Normal
396
2413
1.97
24.68
7.7
4.0
%
76.6
85.2
11.42
389
2347
(3013707) Erythrocyte sedimentation rate by Westergren method
497
6764
0.54
23.33
3.0
4.2
mm/h
19.2
14.2
7.26
449
6151
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
110
395
2.97
23.01
2.6
2.6
u/ml
0.3
0.4
2.22
63
239
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
172
776
2.43
22.90
1.6
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
465
3094
1.84
21.44
3.5
2.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
110
2468
0.39
20.68
1.5
1.7
mmol/l
1.4
1.3
0.19
98
2023
(3023183) Ammonium ion [Moles/volume] in Plasma
73
239
3.19
17.86
2.0
2.6
umol/l
42.1
33.3
1.43
52
198
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
259
4084
0.53
17.85
3.5
5.4
ug/l
2.8
4.2
0.64
206
3597
(3013650) Neutrophils [#/volume] in Blood by Automated count
674
5198
1.71
17.22
30.3
8.9
e9/l
4.5
4.2
1.69
630
4518
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
192
3284
0.50
16.89
3.8
4.7
%
20.9
21.6
0.24
86
1696
(3009542) Hematocrit [Volume Fraction] of Blood
626
7665
0.60
15.69
42.7
18.6
%
34.3
38.7
18.57
370
4765
(3015377) Calcium [Moles/volume] in Serum or Plasma
476
3425
1.66
15.19
11.4
3.4
mmol/l
2.3
2.3
8.34
453
2924
(3003458) Phosphate [Moles/volume] in Serum or Plasma
234
1378
1.87
15.12
2.8
5.5
mmol/l
1.0
1.0
1.57
219
1260
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
764
8858
0.60
14.53
44.0
16.9
mg/l
41.0
27.3
19.81
741
7208
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
109
492
2.34
14.31
2.1
1.9
ug/l
2.2
1.8
0.11
102
431
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
186
3084
0.53
14.26
1.9
2.2
u/l
156.9
232.3
1.01
170
2882
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
576
4396
1.62
14.21
6.1
4.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
144
2569
0.50
13.83
2.3
2.9
umol/l
339.8
7764.6
10.20
112
2164
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
304
4365
0.59
13.77
2.1
2.1
pmol/l
94.3
93.2
0.14
197
2250
(3028192) IgG subclass 2 [Mass/volume] in Serum
29
59
5.02
13.62
1.1
1.3
g/l
3.5
2.7
1.50
14
43
(3027135) IgG subclass 1 [Mass/volume] in Serum
29
59
5.02
13.62
1.1
1.3
g/l
6.4
7.8
0.68
14
42
(3024139) IgG subclass 3 [Mass/volume] in Serum
29
59
5.02
13.62
1.1
1.3
g/l
0.6
0.4
0.63
14
42
(1761868) Lipid panel - Serum or Plasma
147
2590
0.50
13.53
2.9
3.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
568
7015
0.63
13.48
55.2
22.7
g/l
328.5
331.5
13.39
561
6953
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
126
2334
0.48
13.47
2.5
3.3
ug/l
0.6
0.8
2.01
82
1650
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
292
4218
0.59
13.43
2.5
2.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
47
141
3.43
13.25
5.9
5.9
mg/l
12.0
12.3
0.13
42
128
(4062490)
29
61
4.85
13.12
1.2
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
24
44
5.55
12.62
1.2
2.5
e6/l
18638.5
870.9
0.52
17
36
(3012501) Base excess in Blood by calculation
63
234
2.79
12.38
4.7
5.4
mmol/l
2.9
2.7
0.16
51
164
(3044889) 12 lead EKG panel
537
6650
0.64
12.21
4.3
4.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
130
683
2.02
11.62
7.1
9.4
%
94.5
93.9
1.19
130
677
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
338
2365
1.61
11.34
3.3
2.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
62
243
2.64
11.01
1.1
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
16
22
7.36
11.00
1.1
4.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
72
305
2.45
10.89
2.2
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
314
2199
1.59
10.34
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
239
3452
0.61
10.16
2.1
3.2
ng/l
1415.2
1754.0
0.60
214
2990
(3002385) Erythrocyte distribution width [Ratio]
594
7084
0.67
10.14
53.3
20.9
%
15.3
13.9
63.65
582
6907
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
1284
0.42
10.00
1.1
1.3
u/ml
19.3
16.2
0.07
17
440
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
62
1342
0.43
9.84
1.1
1.3
iu/ml
63.0
41.6
0.42
14
426
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
264
1799
1.61
9.68
1.9
1.9
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
62
261
2.45
9.53
10.2
6.2
mmol/l
105.6
105.3
0.17
55
237
(3039000) Anion gap in Blood
62
261
2.45
9.53
10.2
6.2
mmol/l
10.8
11.3
0.88
55
237
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
118
642
1.93
9.52
1.9
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
199
1274
1.68
9.32
1.8
1.8
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
29
82
3.60
8.99
1.1
1.2
nmol/l
1.1
1.5
0.99
23
72
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
197
1272
1.66
8.90
1.9
1.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
73
341
2.22
8.86
9.5
6.0
mmol/l
1.5
1.4
0.97
63
300
(3012516) Albumin [Mass/volume] in Urine
217
3121
0.63
8.77
2.6
3.3
mg/l
143.5
316.8
1.21
132
1999
(3020779) Urea [Moles/volume] in Serum or Plasma
157
961
1.73
8.64
2.7
7.1
mmol/l
8.0
11.2
6.27
145
916
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
120
3.06
8.64
1.1
1.1
iu/ml
44.4
103.6
—
5
21
(3002173) Hemoglobin [Mass/volume] in Arterial blood
170
1067
1.70
8.54
8.5
8.0
g/l
113.9
120.6
5.12
162
1029
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
18
37
4.93
8.38
1.2
2.4
e6/l
34130.6
45990.4
—
10
24
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
107
589
1.90
8.34
9.8
10.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
277
3740
0.66
8.22
2.2
2.2
nmol/l
66.1
78.8
11.28
254
3245
(40758558) Short blood count panel - Blood
311
2277
1.50
8.08
23.6
6.6
—
—
—
0
0
(3020891) Body temperature
86
446
2.00
7.98
6.9
4.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
17
35
4.91
7.90
1.1
2.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
124
731
1.78
7.76
10.7
6.3
mmol/l
24.5
24.6
0.14
115
687
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
40
4.56
7.66
1.2
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
65
1266
0.48
7.65
3.4
4.8
%
33.5
32.8
0.16
40
801
(3009508) Creatinine [Moles/volume] in Urine
229
3164
0.66
7.43
2.5
3.2
mmol/l
7.0
7.3
0.49
184
2593
(3018418) pH of Serum or Plasma
388
3012
1.43
7.33
5.7
4.1
ph
7.4
7.4
0.36
99
560
(3004588) Protein electrophoresis panel - Serum or Plasma
31
786
0.38
7.13
1.9
2.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
127
774
1.72
7.08
7.8
4.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
16
35
4.62
6.94
1.1
2.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
175
1168
1.59
6.84
8.3
7.6
%
96.9
95.4
5.91
167
1128
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
557
4654
1.38
6.67
7.6
6.1
mmol/l
1.2
1.2
6.83
530
4180
(3020682) Albumin/Creatinine [Ratio] in Urine
247
3305
0.68
6.66
3.3
4.0
mg/mmol
21.1
8.8
1.29
144
2088
(3013826) Glucose [Moles/volume] in Serum or Plasma
671
5787
1.38
6.56
8.2
5.0
mmol/l
8.0
6.8
22.15
651
5451
(3021960) Folate [Moles/volume] in Serum or Plasma
185
2601
0.66
6.36
1.6
1.6
nmol/l
21.5
20.4
0.56
173
2186
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
203
1436
1.50
6.07
1.8
2.7
%
18.8
22.3
2.44
175
1220
(3023199) Leukocytes [#/volume] in Pleural fluid
38
159
2.44
6.00
1.2
1.4
e6/l
2718.1
1380.2
0.55
30
115
(3028308) Erythrocytes [#/volume] in Pleural fluid
35
141
2.53
5.98
1.2
1.4
e6/l
36356.0
68867.7
0.50
22
85
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
37
809
0.44
5.97
2.9
3.7
ng/l
121.4
94.6
0.77
30
696
(3026782) Osmolality of Urine
274
2062
1.43
5.95
2.9
2.9
mosm/kgh2o
538.4
552.9
0.48
247
1753
(3012544) pH of Venous blood
153
1022
1.57
5.94
3.2
3.7
—
7.4
—
0
5
(3003434) Protein [Mass/volume] in Pleural fluid
41
180
2.32
5.84
1.1
1.4
g/l
36.1
30.6
1.02
36
161
(3045788) Cell count panel - Pleural fluid
32
126
2.58
5.74
1.2
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
149
999
1.56
5.69
3.0
3.6
kpa
5.6
5.9
2.69
143
964
(3002032) Base excess in Venous blood by calculation
148
992
1.56
5.66
3.1
3.6
mmol/l
1.9
2.1
0.20
121
789
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
15
37
4.09
5.64
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
15
37
4.09
5.64
1.1
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
183
1286
1.50
5.63
8.1
7.3
mmol/l
1.2
1.2
0.02
156
1006
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
165
2.35
5.56
4.0
3.2
%
60.9
59.8
0.23
38
165
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
182
1282
1.50
5.54
8.1
7.3
kpa
5.0
5.1
0.36
173
1233
(3027801) Oxygen [Partial pressure] in Arterial blood
182
1283
1.50
5.52
8.1
7.3
kpa
14.0
11.8
6.18
172
1234
(3004789) Transferrin [Mass/volume] in Serum or Plasma
209
1516
1.46
5.49
1.8
2.6
g/l
2.2
2.3
1.08
204
1400
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
42
192
2.23
5.46
1.2
1.7
nmol/l
0.6
0.9
2.93
36
156
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
46
220
2.14
5.36
1.9
2.3
%
230.5
203.8
1.27
40
206
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
64
350
1.88
5.16
1.3
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
585
5057
1.32
5.05
8.0
6.9
mmol/l
1.2
1.2
4.63
472
4257
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
43
823
0.50
4.79
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
393
0.30
4.71
1.4
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
427
3566
1.31
4.61
2.8
2.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
33
147
2.28
4.60
1.2
1.7
—
—
—
0
0
(3000492) Spirometry study
37
734
0.49
4.60
1.2
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
181
2.14
4.52
1.2
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
441
0.35
4.48
1.3
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
376
3098
1.32
4.44
3.3
3.5
e6/l
25.6
101.1
2.87
311
2436
(3007930) Methemoglobin/Hemoglobin.total in Blood
77
467
1.69
4.43
9.2
4.9
%
1.0
0.9
1.81
69
440
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
157
2.20
4.37
3.3
2.9
e9/l
4.4
4.6
0.11
34
157
(4094501)
6
240
0.25
4.37
1.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
77
471
1.68
4.30
9.2
4.8
%
1.8
1.6
1.73
69
444
(3014111) Lactate [Moles/volume] in Serum or Plasma
134
934
1.49
4.29
4.5
7.3
mmol/l
1.6
1.4
0.61
129
896
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
83
1280
0.62
4.25
17.5
8.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
122
836
1.51
4.24
2.8
2.9
kpa
4.6
4.4
0.25
116
804
(3022145) Colonoscopy Study observation
62
1026
0.58
4.23
1.1
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
51
3.17
4.22
1.1
1.2
mmol/l
12.8
11.7
—
9
18
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
78
484
1.66
4.13
2.4
3.8
mmol/l
24.4
24.2
0.25
73
439
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
116
2.36
4.11
1.3
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
47
252
1.90
4.08
1.2
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
58
2.96
4.02
7.7
3.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
128
897
1.48
4.00
5.1
8.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
28
124
2.29
3.99
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
45
242
1.89
3.88
1.2
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
90
2.47
3.73
1.3
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
342
2841
1.29
3.69
3.3
3.4
e6/l
0.6
0.5
0.28
282
2188
(3035350) Ketones [Presence] in Urine by Test strip
379
4435
0.78
3.66
3.7
4.1
estimate
0.0
0.0
0.00
103
831
(40768443) Skin Pathology biopsy report
16
398
0.39
3.62
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
7
233
0.30
3.62
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
165
2160
0.72
3.60
3.8
4.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
118
832
1.47
3.59
7.1
3.8
mmol/l
1.2
1.2
0.63
108
717
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
26
3.87
3.52
1.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
381
4434
0.79
3.45
4.8
5.4
estimate
0.0
0.0
0.00
102
834
(3013512) EKG study
253
3097
0.77
3.45
3.9
4.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
444
0.44
3.44
1.6
2.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
57
912
0.61
3.42
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
159
1194
1.38
3.42
1.6
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
40
217
1.87
3.39
1.1
1.2
titre
114.0
88.6
—
5
14
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
82
2.46
3.39
1.3
1.8
—
—
—
0
0
(4281824)
23
101
2.30
3.37
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
357
0.38
3.37
1.1
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
68
1039
0.63
3.36
1.1
1.3
titre
435.6
497.8
—
9
232
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
27
3.73
3.36
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
154
2005
0.73
3.22
4.0
4.5
kg/l
1.0
1.0
0.21
29
298
(3009261) Glucose [Presence] in Urine by Test strip
389
4488
0.80
3.19
3.7
4.1
estimate
0.0
0.0
0.50
97
815
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
145
1086
1.38
3.17
6.7
3.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
237
1.80
3.17
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
237
1.80
3.17
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
322
2706
1.26
3.09
3.3
3.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
214
0.32
3.08
1.1
1.2
—
33.1
—
0
12
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
423
0.46
3.06
1.0
1.2
iu/ml
269.9
148.9
—
8
149
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
120
2.11
3.00
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
176
0.28
2.98
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
16
63
2.56
2.96
1.1
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
109
789
1.42
2.91
3.4
4.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
203
0.34
2.81
1.1
1.2
—
2.6
—
0
24
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
205
0.34
2.81
1.1
1.2
—
3.2
—
0
32
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
54
831
0.63
2.78
1.4
1.5
—
—
—
0
0
(4010399)
42
682
0.60
2.72
1.1
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
37
2.99
2.69
1.1
2.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
170
0.29
2.69
1.2
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
320
3708
0.81
2.61
2.2
2.8
ug/l
284.0
156.9
5.71
297
3340
(3014051) Protein [Presence] in Urine by Test strip
9
225
0.40
2.57
1.6
2.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
181
2230
0.78
2.52
1.8
1.8
nmol/l
1352.3
1189.3
1.50
150
1647
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
257
0.38
2.52
4.0
1.4
—
—
—
0
0
(3036489) Thrombin time
49
310
1.61
2.50
1.8
1.9
s
24.9
21.9
1.15
44
282
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
283
0.42
2.48
1.3
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
359
3120
1.22
2.46
4.2
5.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
253
0.39
2.44
1.0
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
176
0.34
2.41
1.0
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
259
2179
1.24
2.41
2.5
2.7
e6/l
7.0
4.6
1.20
235
1922
(40768793) Breast Pathology biopsy report
7
193
0.36
2.41
1.3
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
26
139
1.89
2.38
1.9
2.0
%
89.7
89.5
0.04
26
139
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
147
1.86
2.34
3.7
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
369
0.51
2.33
1.4
2.9
g/l
0.5
0.3
—
8
142
(3035880) pH of Pleural fluid
16
72
2.24
2.28
1.1
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
257
0.42
2.24
1.4
1.8
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
61
0.00
2.24
0.0
1.2
—
5.5
—
0
14
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
188
2274
0.79
2.23
1.6
1.7
pmol/l
478.7
16392066.8
1.50
154
1818
(40760888) Immunoglobulin light chains.free panel - Serum
12
270
0.44
2.23
1.7
3.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
270
0.44
2.23
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
283
0.45
2.22
3.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
165
1.78
2.20
1.3
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
594
6428
0.84
2.18
3.8
4.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
167
0.36
2.15
1.2
1.2
—
8.2
—
0
13
(3049717) Cytology report of Urine Cyto stain
30
496
0.59
2.14
3.1
2.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
183
1.71
2.09
1.3
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
131
1.85
2.09
1.2
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
160
1955
0.79
2.07
1.6
1.7
mg/l
3.5
1.4
2.45
143
1543
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
63
2.24
2.01
1.2
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
63
2.24
2.01
1.2
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
148
1.77
1.99
1.2
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
148
1.77
1.99
1.3
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
25
142
1.78
1.94
1.3
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
171
0.41
1.92
2.7
3.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
120
1503
0.78
1.91
1.3
1.4
g/l
2.6
2.7
0.42
72
861
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
411
3695
1.17
1.85
3.5
3.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
352
3937
0.85
1.83
21.2
10.3
e9/l
0.0
0.0
0.99
273
3212
(3048689) Calprotectin [Mass/mass] in Stool
65
880
0.72
1.79
1.5
2.1
ug/g
154.6
141.0
0.08
53
691
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
580
5368
1.16
1.78
5.7
3.2
u/l
254.1
54.5
23.90
550
4884
(3000919) Neutrophils/100 leukocytes in Pleural fluid
10
41
2.45
1.75
1.3
1.2
%
46.5
29.4
—
10
36
(3019832) Treponema pallidum Ab [Presence] in Serum
12
244
0.49
1.75
1.5
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
47
0.00
1.70
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
75
2.01
1.70
1.2
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
139
1679
0.80
1.64
1.2
1.2
u/ml
4.4
1.4
0.39
34
413
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
94
735
1.30
1.63
1.2
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
33
214
1.56
1.61
1.4
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
42
0.00
1.52
0.0
1.2
—
48.8
—
0
13
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
43
0.00
1.52
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
86
1.87
1.50
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
35
234
1.51
1.50
2.1
2.8
%
13.4
15.8
—
10
126
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
210
1.54
1.50
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
91
718
1.29
1.49
1.2
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
63
472
1.35
1.48
1.1
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
10
45
2.23
1.46
1.4
1.3
%
1.6
3.2
—
10
37
(40761535) Cells panel - Urine sediment
68
884
0.75
1.46
4.2
3.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
152
0.46
1.44
1.1
1.2
—
39.6
—
0
13
(3052592) Norovirus Ag [Presence] in Stool
5
16
3.13
1.44
1.0
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
60
2.01
1.38
1.3
4.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
197
0.50
1.37
1.7
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
43
593
0.71
1.37
1.2
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
23
2.62
1.37
1.2
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
385
3512
1.14
1.36
3.7
4.0
e6/l
71.9
120.4
0.93
313
2600
(44790048)
19
112
1.71
1.36
1.1
1.5
—
—
—
0
0
(44806118)
19
112
1.71
1.36
1.1
1.5
—
—
—
0
0
(44790047)
19
112
1.71
1.36
1.1
1.5
—
—
—
0
0
(44790049)
19
112
1.71
1.36
1.1
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
38
0.00
1.34
0.0
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
80
1003
0.78
1.33
2.2
2.5
ug/l
2.1
6.6
14.00
72
867
(40765096) Chromosome analysis panel by Banding
0
40
0.00
1.32
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
24
2.51
1.30
1.7
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
21
129
1.64
1.30
1.0
1.4
u/ml
111.4
103.3
—
5
18
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
43
2.10
1.30
1.2
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
65
504
1.31
1.25
4.4
3.9
%
52.2
47.9
0.76
65
495
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
21
326
0.64
1.24
1.3
1.6
—
95.0
—
0
12
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
323
0.64
1.20
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
191
1671
1.17
1.19
3.3
3.1
e6/l
3.1
1.9
0.62
110
951
(3002030) Lymphocytes/100 leukocytes in Blood
458
4258
1.13
1.18
4.1
5.9
%
20.5
26.3
19.47
429
3934
(3023520) Reticulocytes [#/volume] in Blood
79
976
0.80
1.18
1.9
2.6
e9/l
73.5
68.5
0.36
61
761
(40760892) CBC W Ordered Manual Differential panel - Blood
201
1769
1.16
1.17
3.6
4.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
451
4191
1.12
1.17
4.1
6.0
%
8.5
9.0
1.46
426
3893
(3048879) Bone marrow aspiration report
0
33
0.00
1.16
0.0
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
34
0.00
1.16
0.0
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
34
0.00
1.16
0.0
1.1
—
119.1
—
0
8
(3036670) Protein [Mass/volume] in Synovial fluid
0
36
0.00
1.14
0.0
1.2
—
37.2
—
0
19
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
103
1.66
1.13
7.9
3.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
38
514
0.73
1.11
1.6
3.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
153
1327
1.18
1.07
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
67
1.80
1.05
1.3
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
275
0.65
1.03
2.7
2.5
ug/min
93.9
114.5
0.14
12
162
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
672
0.78
1.01
1.7
3.7
mmol/l
2.4
2.0
0.24
34
516
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
133
0.52
0.99
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
175
0.57
0.98
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
148
1.50
0.98
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
161
0.56
0.98
1.6
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.1
—
18.0
—
0
7
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
30
0.00
0.97
0.0
1.1
—
1.1
—
0
8
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
1.3
—
143.6
—
0
23
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
314
3401
0.89
0.94
4.0
4.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
377
4039
0.90
0.92
3.6
4.1
ng/l
42.9
53.0
0.24
308
3097
(3052851) Hemolysis interference index of Serum or Plasma
39
296
1.33
0.92
6.0
3.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
78
1.67
0.91
1.3
1.8
%
12.5
10.2
1.18
13
78
(3032057) Clostridioides difficile [Presence] in Stool
6
28
2.15
0.91
2.0
2.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
32
236
1.37
0.90
4.6
3.5
mmol/l
9.9
7.8
2.16
32
229
(3006504) Eosinophils/100 leukocytes in Blood
444
4172
1.10
0.90
4.1
5.7
%
2.3
2.9
5.18
420
3865
(3022621) pH of Urine by Test strip
51
637
0.79
0.88
2.7
3.2
—
—
—
0
0
(3009343) pH of Capillary blood
57
702
0.80
0.87
1.7
3.7
ph
7.5
7.4
—
7
95
(3023383) Lactate [Moles/volume] in Pleural fluid
8
43
1.87
0.87
1.0
1.4
mmol/l
7.3
3.6
—
8
37
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
58
711
0.81
0.85
1.7
3.7
kpa
4.9
5.2
1.99
50
663
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
191
0.62
0.85
1.5
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
191
0.62
0.85
1.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
248
1.34
0.84
1.3
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
33
249
1.33
0.82
4.5
3.4
mmol/l
1.9
1.6
0.49
33
242
(3017181) Myelocytes/100 leukocytes in Blood
91
777
1.19
0.81
2.4
4.2
%
1.1
0.9
0.38
58
251
(3021901) Oxygen saturation in Capillary blood
14
212
0.66
0.80
2.1
2.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
1593.8
—
0
24
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
112.3
—
0
19
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
0.3
—
0
18
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
26
0.00
0.78
0.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
96
0.52
0.78
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
31
234
1.33
0.78
2.2
4.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
122
0.57
0.78
1.4
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
98
0.51
0.78
1.2
1.2
—
78.7
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.1
—
149.5
—
0
27
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
69
819
0.83
0.76
1.8
2.1
nmol/l
423.8
373.4
1.00
64
737
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
67
1.65
0.75
1.4
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
90
1040
0.85
0.73
2.8
4.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
6
106
0.56
0.72
1.2
1.3
iu/l
46.5
27.1
—
6
91
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
92
1.53
0.72
1.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
92
1.53
0.72
1.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
92
1.53
0.72
1.0
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
26
1.93
0.70
1.4
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
26
1.93
0.70
1.2
2.9
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
13
85
1.54
0.69
1.3
1.3
u/l
11.8
14.6
0.98
13
77
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
119
0.59
0.68
1.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
92
0.54
0.67
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
548
0.81
0.66
1.2
1.9
g/l
1.6
1.5
0.33
37
480
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
268
1.28
0.66
1.2
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
751
7294
1.08
0.65
31.1
7.6
u/l
189.7
80.4
45.73
733
6785
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
44
1.59
0.65
1.4
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
62
1.62
0.65
5.4
2.4
—
—
—
0
0
(4034850)
21
281
0.74
0.64
19.9
11.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
440
4188
1.08
0.64
3.9
5.7
%
63.1
58.4
9.49
414
3891
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
292
0.75
0.64
1.4
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
80
694
1.16
0.62
2.5
4.0
%
0.6
0.6
0.01
46
185
(3026389) Candida sp identified in Specimen by Organism specific culture
6
104
0.57
0.62
1.5
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
34
271
1.26
0.61
1.2
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
216.8
—
0
5
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
23
0.00
0.58
0.0
1.0
—
104.4
—
0
16
(3017732) Neutrophils [#/volume] in Blood
48
571
0.83
0.58
5.1
3.2
e9/l
3.8
4.1
0.30
40
410
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
86
0.58
0.56
1.2
1.2
mmol/l
8.8
7.3
—
5
59
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
229
0.74
0.56
3.5
3.7
mg/l
46.7
28.9
0.67
12
147
(3024928) Oxygen saturation in Venous blood
30
239
1.26
0.55
2.7
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
267
1.24
0.54
1.2
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
60
1.50
0.54
1.4
1.6
umol/l
12.2
15.3
—
9
55
(3022096) Basophils/100 leukocytes in Blood
425
4064
1.07
0.54
4.1
5.7
%
0.6
0.7
3.00
401
3770
(3000330) Specific gravity of Urine by Test strip
45
532
0.84
0.52
4.6
4.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
100
0.60
0.51
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
75
1.47
0.50
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
168
0.71
0.50
1.1
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
252
2673
0.93
0.49
2.0
2.2
mg/l
3.1
3.1
0.13
228
2246
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
109
0.64
0.48
3.0
3.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
346
1.19
0.47
1.6
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
214
2006
1.08
0.47
3.4
4.2
ng/l
71.2
320.8
5.71
172
1719
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
129
1.32
0.46
1.1
1.1
u/ml
243.3
327.0
—
10
71
(3000764) Benzodiazepines [Presence] in Urine
5
81
0.62
0.46
1.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
81
0.62
0.46
1.2
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
78
1.41
0.43
1.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
31
1.62
0.43
1.0
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
0.5
—
0
9
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
59
1.36
0.41
1.0
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
114
1.32
0.41
1.9
2.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
17
0.00
0.40
0.0
2.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
34
1.47
0.40
1.4
1.4
nmol/l
0.1
0.2
—
5
21
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(4133840)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.8
—
2.1
—
0
8
(40762814) Titanium [Mass/volume] in Blood
0
19
0.00
0.39
0.0
2.0
—
2.9
—
0
7
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
158
0.76
0.37
1.1
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
46
524
0.87
0.37
1.3
1.8
g/l
1.0
1.6
2.49
41
478
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
37
1.35
0.37
1.2
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
37
1.35
0.37
1.2
3.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
77
697
1.11
0.37
2.1
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
116
1.30
0.37
1.3
4.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
191
0.78
0.37
1.2
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
76
0.66
0.35
1.2
1.4
—
35.7
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
35
301
1.17
0.35
4.7
5.1
—
—
—
0
0
(44806420)
6
43
1.40
0.35
2.2
2.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
102
1103
0.92
0.34
1.8
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
100
1.30
0.33
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
71
646
1.11
0.32
1.6
2.8
g/l
9.9
11.1
1.77
55
589
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
137
1.24
0.32
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
19
157
1.21
0.29
1.9
2.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
77
836
0.92
0.29
1.6
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
57
1.23
0.29
1.3
2.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
130
1.23
0.28
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
186
1772
1.06
0.28
3.2
2.9
e6/l
1.2
1.1
0.35
105
1048
(3021440) Promyelocytes/100 leukocytes in Blood
79
730
1.09
0.27
2.5
4.3
%
0.1
0.1
0.19
54
229
(3003327) Ova and parasites identified in Stool by Light microscopy
19
226
0.84
0.27
1.7
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
49
442
1.11
0.27
1.8
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
131
1.22
0.27
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
52
572
0.90
0.26
2.5
2.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
118
1252
0.94
0.26
1.9
4.0
u/l
258.9
249.9
0.20
111
1182
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
132
1.22
0.25
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
132
1.22
0.25
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
132
1.22
0.25
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
687
1.08
0.24
2.6
4.3
%
0.0
0.5
0.55
48
198
(3027944) Amphetamines [Presence] in Urine
6
82
0.73
0.24
1.2
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
82
0.73
0.24
1.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
84
0.71
0.24
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
84
0.71
0.24
1.2
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
171
1.17
0.23
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
93
0.75
0.22
1.0
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
135
0.81
0.22
2.2
2.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
26
294
0.88
0.21
1.7
3.3
mmol/l
24.4
25.3
0.29
20
258
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025315) Body weight
0
10
0.00
0.21
0.0
4.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.8
—
7.8
—
0
7
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
14
0.00
0.20
0.0
4.9
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.8
—
15.5
—
0
14
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
94.5
—
0
14
(4146454)
11
133
0.83
0.19
2.2
2.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
50
540
0.92
0.19
1.2
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
238
0.88
0.18
2.0
2.4
g/l
114.3
128.6
1.36
15
183
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
121
0.82
0.18
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
69
0.72
0.17
5.8
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
120
0.83
0.16
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
467
1.07
0.16
1.1
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
86
0.81
0.14
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
87
0.80
0.14
4.4
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
43
401
1.08
0.14
1.8
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
90
0.78
0.14
1.1
2.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
131
1.15
0.14
1.4
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
449
4426
1.02
0.13
3.9
5.5
e9/l
0.6
0.6
1.23
370
3780
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
94
1.17
0.13
1.0
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
242
2473
0.97
0.13
3.8
4.4
estimate
0.0
0.0
0.50
90
789
(3027945) Reticulocytes/100 erythrocytes in Blood
126
1302
0.96
0.13
1.6
2.5
%
2.1
1.8
1.27
119
1152
(3028626) Oxygen [Partial pressure] in Capillary blood
23
252
0.91
0.12
1.7
3.0
kpa
7.8
7.8
0.02
18
230
(3022217) INR in Platelet poor plasma by Coagulation assay
151
1551
0.97
0.11
15.8
29.1
inr
1.3
1.4
0.33
26
204
(3006315) Basophils [#/volume] in Blood
450
4445
1.02
0.11
3.9
5.5
e9/l
0.0
0.0
0.51
373
3810
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
105
1.14
0.11
1.0
1.2
nmol/l
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
146
0.89
0.10
1.8
1.9
pg
31.3
32.3
0.25
13
146
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
44
1.14
0.10
1.0
4.0
u/l
159.4
214.8
—
5
44
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
72
747
0.96
0.09
4.7
3.0
ml/min/173m2
62.9
59.8
0.34
28
314
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
105
1020
1.03
0.09
2.5
3.0
ng/l
240.9
243.1
0.02
97
940
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
399
1.05
0.09
2.3
2.9
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
457
4527
1.02
0.08
4.0
5.6
e9/l
1.5
1.9
8.95
392
3952
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
5
62
0.81
0.08
1.8
2.7
—
38.5
—
0
21
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
63
0.79
0.08
2.2
2.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
74
0.81
0.07
2.7
2.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
636
6320
1.01
0.07
4.6
4.9
e6/l
10.8
2410.7
—
8
112
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
336
0.95
0.07
1.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
99
1.11
0.06
1.0
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
148
1.08
0.06
1.4
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
151
0.93
0.05
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
80
786
1.02
0.03
1.3
1.8
%
1.7
1.6
0.35
58
638
(3007853) Bacteria identified in Skin by Aerobe culture
113
1145
0.99
0.03
1.6
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
159
0.94
0.03
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
231
1.04
0.02
1.1
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
231
2298
1.01
0.02
3.3
3.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
458
4593
1.00
0.02
4.1
5.7
e9/l
0.2
0.2
2.63
390
4016
(3026008) Bacteria identified in Urine by Culture
318
3186
1.00
0.00
3.0
3.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
10
96
1.04
0.00
2.0
3.5
mg/l
7.5
36.6
—
5
79
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
106
1.04
0.00
1.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
13
129
1.01
0.00
3.8
6.6
mmol/l
8.3
7.1
0.70
13
107
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
273
0.99
0.00
1.8
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
66
0.91
0.00
1.2
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024316) Viscosity of Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
2.0
—
1.9
—
0
7
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.6
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
384.8
—
0
5
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
0.3
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
5.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
55
0.91
0.00
1.0
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
51
0.98
0.00
1.6
1.6
—
36.0
—
0
8
(3002523) Influenza virus A Ag [Presence] in Specimen
6
66
0.91
0.00
1.2
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS_ADENO_DUCTAL – Adenocarcinoma and ductal carcinoma of pancreas
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).